期刊文献+

以痰立论辨治甲状腺结节痰血瘀阻型对结节大小以及甲状腺抗体水平的影响 被引量:2

The Influence of Phlegm Theory on Thyroid Nodule Size and Thyroid Antibody Level in Patients with Thyroid Nodule of Phlegm-blood Stasis Type Thyroid Nodule
下载PDF
导出
摘要 目的以"痰"立论辨治甲状腺结节痰血瘀阻型对结节大小以及甲状腺抗体水平的影响。方法选取2019年1月—2020年3月在辽宁中医药大学附属医院内分泌科就诊经辨证均为痰血瘀阻型的90例甲状腺结节患者,按照随机数字表法分为对照组和试验组,各45例。对照组采取常规干预,试验组采取以"痰"立论辨治,比较2组甲状腺结节大小以及甲状腺抗体水平。结果试验组结节最大径、结节体积均低于对照组,差异有统计学意义(P <0.05);试验组甲状腺抗体水平优于对照组,差异有统计学意义(P <0.05)。结论对痰血瘀阻型甲状腺结节患者采取以"痰"立论辨治,可以有效地改善甲状腺结节大小,改善患者的甲状腺功能。 Objective To discuss the effect of "phlegm"on the size of thyroid nodules and the level of thyroid antibodies caused by the type of phlegm and blood stasis. Methods From January 2019 to March 2020, 90 patients with thyroid nodules in Affiliated Hospital of Liaoning University of Traditional Chinese Medicine were randomly divided into control group and observation group, with 45 cases in each group. The control group was treated with routine intervention, and the experimental group was treated with "phlegm". The thyroid nodule size and thyroid antibody levels of the two groups were compared. Results The maximum diameter and volume of nodules in the experimental group were lower than those in the control group, and the differences were statistically significant(P <0.05). The thyroid antibody level of the experimental group was better than that of the control group, and the difference was statistically significant(P <0.05). Conclusion The treatment of thyroid nodule with phlegm can effectively improve the size of thyroid nodule and thyroid function in patients with phlegm and blood stasis.
作者 李慧 LI Hui(Department of Endocrinology,Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Liaoning Province,Shenyang 110032,China)
出处 《中国中医药现代远程教育》 2021年第18期99-100,共2页 Chinese Medicine Modern Distance Education of China
关键词 瘿瘤 甲状腺结节 痰血瘀阻型 “痰”立论 goiter thyroid nodules phlegm-blood stasis type "phlegm"theory
  • 相关文献

参考文献4

二级参考文献32

  • 1The National Academy of Clinical Biochemistry (NACB).Laboratory Medicine Practice Guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid ,2003,13 : 3- 126.
  • 2The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 2006,16 : 109-141.
  • 3Teng WP, Shah ZY, Teng XC, et al. Effect of iodine intake on thyroid disease in China. N Engl J Med, 2006, 354:2783-2793.
  • 4Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA, 1995, 273:808-812.
  • 5邢家骝.131I治疗甲状腺功能亢进.邢家骝.131I治疗甲状腺疾病.北京:人民卫生出版社,2002.152-196.
  • 6中华医学会核医学分会.甲状腺疾病的131I治疗.中华医学会.临床技术操作规范·核医学分册.北京:人民军医出版社,2004.175-177.
  • 7滕卫平,曾正培,李光伟,等.中国甲状腺疾病诊治指南[S].中华医学会内分泌学分会,2008:60.
  • 8Levy Michael H,Back Anthony,Benedetti Costantino,Billings J Andrew,Block Susan,Boston Barry,Bruera Eduardo,Dy Sydney,Eberle Catherine,Foley Kathleen M,Karver Sloan Beth,Knight Sara J,Misra Sumathi,Ritchie Christine S,Spiegel David,Sutton Li.NCCN clinical practice guidelines in oncology: palliative care. Journal of the National Comprehensive Cancer Network : JNCCN . 2009
  • 9高明.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床,2012,29(17):1249-1272. 被引量:738
  • 10黎涛.甲状腺结节综合药物治疗的临床效果分析[J].中国医药科学,2013,3(2):64-65. 被引量:9

共引文献212

同被引文献40

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部